|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/50 |
| (11) | Number of the document | 2925775 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13857983.4 |
| Date of filing the European patent application | 2013-11-26 | |
| (97) | Date of publication of the European application | 2015-10-07 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/071803 |
| Date | 2013-11-26 |
| (87) | Number | WO 2014/085365 |
| Date | 2014-06-05 |
| (30) | Number | Date | Country code |
| 201261730777 P | 2012-11-28 | US | |
| 201361887108 P | 2013-10-04 | US | |
| 201361893720 P | 2013-10-21 | US |
| (72) |
LING, Lei, US
LINDHOUT, Darrin, Anthony, US
|
| (73) |
NGM Biopharmaceuticals, Inc.,
333 Oyster Point Blvd., South San Francisco CA 94080,
US
|
| (54) | COMPOSITIONS AND METHODS FOR TREATMENT OF METABOLIC DISORDERS AND DISEASES |
| COMPOSITIONS AND METHODS FOR TREATMENT OF METABOLIC DISORDERS AND DISEASES |